ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

SCLP Scancell Holdings Plc

8.92
-0.63 (-6.60%)
30 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Holdings Plc LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.63 -6.60% 8.92 9.10 9.50 9.55 9.30 9.55 186,473 16:35:13
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 5.27M -11.94M -0.0129 -7.21 86.29M
Scancell Holdings Plc is listed in the Pharmaceutical Preparations sector of the London Stock Exchange with ticker SCLP. The last closing price for Scancell was 9.55p. Over the last year, Scancell shares have traded in a share price range of 7.65p to 18.125p.

Scancell currently has 927,819,977 shares in issue. The market capitalisation of Scancell is £86.29 million. Scancell has a price to earnings ratio (PE ratio) of -7.21.

Scancell Share Discussion Threads

Showing 12051 to 12073 of 66200 messages
Chat Pages: Latest  488  487  486  485  484  483  482  481  480  479  478  477  Older
DateSubjectAuthorDiscuss
18/10/2017
09:02
Tosh, and don't forget RG stated 2 years ago " Funding is easy for a Company with a successful Phase 11 behind it ".
panama7
18/10/2017
08:47
B... the change in leadership and the funding deadline are one and the same... I dont give a flying one about RG's departure( it should have happened a long long time ago ) but what i do care about, is FUNDING, and whether you like it or not RG made a specific statement and therein confirmed a timeline.
If this timeline is missed, then all bets are off.

tosh123
18/10/2017
08:44
Bermuda. The way I read it is,

Scancell aim to do a deal to cause the share price to rise off the back of which they will be in a better place to go and secure funding?

But does this mean the deal they are aiming for comes with no cash / up front payments etc?

rhatton
18/10/2017
08:38
Tosh,

You underestimate the intelligence of those attending the AGM and also those reading your comments. RG was clear that he hoped to complete a deal by the time he handed over to CH but by no means gave any guarantees. There is no finite target date on which any ongoing negotiations or due diligence suddenly stop simply because the CEO has changed to a non-exec role.

The make or break event here is not the change in leadership, it's if the Company come back to the market for funding. Then we will know that there is no deal on the table. So I stand by my comments that nothing has changed.

bermudashorts
18/10/2017
08:25
ONW 00:28... Wholeheartedly agree.
B... The difference between this announcement and all the other " failed " announcements, is that rather than a wishy washy, some time this year, time span, at this years AGM, RG makes a very specific statement.
This now provides a finite target date, so by definition, if it is missed, then the share price will almost certainly be under massive pressure... again !
I just hope that this is not another RG fairy tale.

tosh123
18/10/2017
08:24
10acious - confirmation bias works both ways
bermudashorts
18/10/2017
08:16
Heartening to hear a level of optimism being expressed here. Sometimes they do get lost in the apologies for doing so, and the need to justify still being ASTUTE. Better than nothing though. Enjoy your day.
chelsea35
18/10/2017
02:25
I still think they might be bluffing over the cancelled 2013 trade sale
kreature
18/10/2017
00:28
BoB of course I believe them in the same way that I've believed them in the past. My point re response to Wanderer was simply that if we fail to achieve a deal of some description between now and the new CEO's appointment we run the risk of facing some share price weakness either because of disappointment or worse another round of cash raising using share issuance in one form or another. I think you also mentioned that the BOD had not made any statement regarding a change in fundraising strategy... That is true to a degree, but... When the CEO makes a point of saying something along the lines of wanting to bequeath his successor a job which requires him to spend money already in place it's rather a broad hint that a deal is becoming imminent and IMO if it doesn't materialise the share price is likely to suffer.
So as you can see I hope that the broad hints dropped at the AGM come to fruition because If RG hands over the reins to our new CEO in January without there having been a funding RNS of some description I fear the market might well react unhelpfully.
I do hope you don't suggest I'm calling RG a liar... I am not... But it would,IMO, be very unfortunate if optimistic comments regarding funding (or validating deal/deals of some sort) within a pretty tight time horizon were not realised as I don't think Scancell can afford another poorly timed unrealised optimistic forecast.
I hope that helps explain my earlier posts,and I'm more than happy to discuss /elaborate further if needed.
AIMO
Atb

oldnotwise
17/10/2017
22:39
I was going to go on to say that I'm not sure I understand the points Tosh and ONW were trying to make today. Clearly I understand the need for funding but what's changed? Why, these posts now about make or break? Nothing new was announced at the AGM in terms of strategy for funding.
bermudashorts
17/10/2017
22:32
10acious,

"The Board has made significant progress in partnering discussions on both its ImmunoBody® and Moditope® platform product candidates, and progress has continued to be very encouraging since the year end. "

"The Company is continuing discussions on potential commercial partnerships for the Moditope® platform alongside its clinical development plans, with multiple partnering discussions in progress."

"There has been substantial interest in Scancell's SCIB2 product for the treatment of NSCLC. We have already announced a collaboration partnership with the Addario Foundation and we are actively negotiating with other interested parties on development and commercial partnership opportunities. "

"The Board believes that further funding could be best achieved following the execution of a further partnership on the ImmunoBody® or Moditope® platform. "

hxxps://investegate.co.uk/scancell-hlds--sclp-/rns/final-results/201709130700045643Q/

bermudashorts
17/10/2017
22:26
Bermudashorts, hi, sorry to but in, I think I may have missed something or not understood or misread. Could you please point me to the RNS that informed us of the ongoing discussions you make ref. to.Thanks.
10acious
17/10/2017
22:06
ONW - Scancell have stated in RNS's and reiterated at the AGM that they are in discussions with potential partners on both platforms. Do you believe them yes or no?
bermudashorts
17/10/2017
18:00
Wanderer... well it's all a punt to a degree... good luck with the short term.
Wonder how many others are doing much the same.... Naw.. wouldn't be many would there?? ;-)
Who knows, let's hope the "news" materialises before they decide to cash in... unless some less charitable hope they cash in before the "News"... but then we'll have to agonise over a falling share price ..
All decision, decisions hehe..
ATB

oldnotwise
17/10/2017
16:57
Wanderer
Interesting point, one that's not been wasted on me. That's why I decided to live "in hope" after the AGM... it all sounds fine.... doesn't it? ;-)
I know we've all been here before , you know naff share price performance with great Science and nothing concrete on the Commercials.. In fact the fact that we didn't close a deal in 2015 is seen as a positive (well, at least we got an approach)! That in itself isn't anything to take too much against it happens to the best of companies on their way to success.
So I've chosen to take the path I have (Holding) because I hope that we're not being taken for a ride and that RG is sufficiently well endowed with options to see that a handover might be the best way to get the company's fortunes going on the right path. If I had to choose between a multimillion dollar "payday" or a bit of Kudos I know which I'd choose!
So yes, that's why I didn't take out my holding in SCLP post AGM even though it was tempting to think "why semaphore a fundraiser?" when we can all see without a deal of some sort we're gonna have one hell of a job getting any movement in share price which will materially enhance a fundraising. So I hope for the "deal" whatever that is and that's also why I think (just like Tosh) we've got one hell of a problem without it!
That's how I see it, high risk (without inside knowledge) play on Make or Break!
AIMO
ATB

oldnotwise
17/10/2017
16:42
On the other hand Tosh and ONW why would RG be stepping down if deals of any kind are just around the corner? Imo Scancell are struggling to get funding hence the departure of RG
wanderer1210_0
17/10/2017
16:05
Tosh
What you're saying is nothing different from what you've posted for a long time now, but it's interesting to see you've gained support from some unlikely directions. Having listened to the proceedings at the AGM my first thought was that this is "make or break" but interestingly I found myself almost alone with that view!
Not in any way disagreeing with your comments, and the fact that this (as you say) could be yet another Bullet in the Foot, but (once again) I'll express my view but be driven by my hope that the goods will be delivered.
It's going to be a very interesting winter here! :-)
AIMO
ATB

oldnotwise
17/10/2017
15:01
C7... Its going to take a damn sight more than an FT share tip or an AGM to move this to the levels required to generate funds at the right price.
Granted they have both helped a bit, but lets not lose sight of the fact that its still at about 14p, which is a country mile away from where it has been, and if capital was needed at this level " AGAIN " we had just as well sell the IP for what ever we could get, and turn the lights out.
Personally, im just hoping that the appointment of a new CEO early next year, indicates that the current BOD are confident of providing him with some tools to work with, rather than a company to dismantle.
The closer it gets to year end without any confirmed deal, the more downward pressure will be applied to the SP, this is now a hail Mary ! IMHO.

tosh123
17/10/2017
12:26
Rec post Tosh, i would say what Lozan says is a statement of the 8leeding obvious though and would apply to any company. Very clear strategy with regard to the SP, I would expect news to achieve a higher share price in the short term. We have seen very good movement on the back of the FT share tip and the AGM, looking forward to where we could go on good news.
chelsea35
17/10/2017
10:00
Having shown their hand, the funding issue is now more important than ever.
Clearly, to have put on record that the BOD need major additional funds, and more importantly, that " they propose to raise these funds themselves " but at a much higher share price than today's meagre 14 odd pence, they are now absolutely tied into getting some form of JV / deal done , before any further progress can be made with the trials.
One hopes that as they have made such a bold statement, that they are confident of agreeing a deal before Jan 2018, and the terms of such a deal, otherwise, they have somewhat shot themselves in the foot...again !
IF... as Lozan quite rightly points out, there is no such deal on the statute book by the end of Jan 2018, then we will have a very grave situation, so lets hope the BOD's confidence is not misplaced, and its just a matter of the patent being granted, before any signatures are put to paper.

tosh123
16/10/2017
21:45
"""All is not as it seems."""

Why??

chelsea35
16/10/2017
18:21
12-Oct-17
11:47:10
14.90
670,966 Buy

One has to ask how a buy of this magnitude followed by further buys today and Friday leaves us with a share price of 14.5p.

All is not as it seems.

terror
16/10/2017
18:03
"in the meantime, don't forget about the question - as yet to be answered, of FUNDING"Yes, when the shares were at 10p you suggested investors should focus on this. I'm pleased I didn't.
wigwammer
Chat Pages: Latest  488  487  486  485  484  483  482  481  480  479  478  477  Older

Your Recent History

Delayed Upgrade Clock